Chase Investment Counsel’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Hold |
|
|||||
|
2025
Q1 | $432K | Hold |
|
|||||
|
2024
Q4 | $454K | Hold |
|
|||||
|
2024
Q3 | $572K | Sell |
|
|||||
|
2024
Q2 | $624K | Sell |
|
|||||
|
2024
Q1 | $693K | Hold |
|
|||||
|
2023
Q4 | $687K | Hold |
|
|||||
|
2023
Q3 | $578K | Sell |
|
|||||
|
2023
Q2 | $843K | Hold |
|
|||||
|
2023
Q1 | $878K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.81M | Hold |
|
|||||
|
2021
Q3 | $2.12M | Hold |
|
|||||
|
2021
Q2 | $2.19M | Hold |
|
|||||
|
2021
Q1 | $1.86M | Sell |
|
|||||
|
2020
Q4 | $3.1M | Hold |
|
|||||
|
2020
Q3 | $2.51M | Hold |
|
|||||
|
2020
Q2 | $2.6M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.97M | Hold |
|
|||||
|
2019
Q2 | $2.4M | Hold |
|
|||||
|
2019
Q1 | $2.57M | Hold |
|
|||||
|
2018
Q4 | $1.95M | Hold |
|
|||||
|
2018
Q3 | $3.23M | Hold |
|
|||||
|
2018
Q2 | $2.65M | Hold |
|
|||||
|
2018
Q1 | $2.55M | Hold |
|
|||||
|
2017
Q4 | $2.6M | Hold |
|
|||||
|
2017
Q3 | $2.84M | Hold |
|
|||||
|
2017
Q2 | $2.48M | Hold |
|
|||||
|
2017
Q1 | $2.24M | Hold |
|
|||||
|
2016
Q4 | $1.85M | Hold |
|
|||||
|
2016
Q3 | $2.25M | Buy |
|